TBA The Biotechnology Initiative

The Voice of Bioscience in Ontario



Greg Hines

Picture

President and CEO, ArcticDx Inc.

Mr. Hines was President, CEO and Director of Tm Bioscience from March 31, 2000 until he sold the company to Luminex Corporation in March of 2007. At Tm Bioscience, Mr. Hines led the design, development and commercialization of a molecular diagnostic platform complete with a menu of molecular tests in the fields of Human Genetics, Pharmacogenetics and Infectious Disease. Tm Bioscience was a publicly traded company on the Toronto Stock Exchange. Prior to this Mr. Hines served as President of Leo Pharma Inc., a research-based pharmaceutical company which Mr. Hines founded in Canada in 1981. In this capacity he brought 8 new medicines through clinical development (phase 2&3), regulatory approval and commercialization. He also served on the Board of Directors of MEDEC and Rx&D. Mr. Hines was the Chairman of the Rx&D Board in 1997/98. Mr. Hines currently serves on the Board of Directors of The Biotechnology Initiative (Toronto), Genesis Genomics Inc. and The Canadian Gene Cure Foundation.